SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-289872
Filing Date
2014-07-31
Accepted
2014-07-31 16:54:10
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d736456d10q.htm 10-Q 190415
2 EX-31.1 d736456dex311.htm EX-31.1 7617
3 EX-31.2 d736456dex312.htm EX-31.2 7645
4 EX-32.1 d736456dex321.htm EX-32.1 7230
  Complete submission text file 0001193125-14-289872.txt   2860440

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT qhoi-20140630.xml EX-101.INS 218502
6 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20140630.xsd EX-101.SCH 52157
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20140630_cal.xml EX-101.CAL 29833
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20140630_def.xml EX-101.DEF 91648
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20140630_lab.xml EX-101.LAB 619830
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20140630_pre.xml EX-101.PRE 210707
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52062 | Film No.: 141006910
SIC: 2834 Pharmaceutical Preparations